Indo Us Biotech Limited — Board Meeting, 26-05-2025: Outcome of Board Meeting

Indo-US Bio-Tech Limited has announced a board meeting to approve the financial results for the quarter and half-year. Revenue climbed to Rs 103.84 Cr from Rs 72.84 Cr the previous year, with net profit nearly doubling to Rs 16.27 Cr. EBITDA growth reflects improved margin control despite rising production costs. Inventories and other equity increased to Rs 58.47 Cr from Rs 42.70 Cr, while interest expenses held steady at Rs 1.49 Cr. The company is focused on boosting R&D and operational efficiency to sustain growth.